References
- Kotani M, Ohmori J, Miyakawa K, Hayama T, Kawatsu R, Terao K. Increased vascular permeability in the thymus of the autoimmune New Zealand mouse. J Anat 1988; 161: 83–93
- Ohmori J, Miyakawa K, Matsuno K, Kotani M. Increased vascular permeability of brucella abortus bacilli in the thymus of NZBW F, mice. Autoimmunity 1991; 10: 99–105
- Ryan G B, Majno G. Acute inflammation. Am J Pathol 1977; 86: 184–276
- Burnet F M, Holmes M C. Thymic changes in the mouse strain NZB in relation to the auto-immune state. J Path Bact 1964; 88: 229–241
- Burnet F M. Mast cell in the thymus of NZB mice. J Path Bact 1965; 89: 271–284
- Burnet F M. Mast cells in the thymus. Thymus. Experimental and Clinical Studies, G EW Wolstenholme, R Porter. J. & A. Churchill, Ltd., London 1966; 335–347
- Vaz N M, Prouvost-Danon A. Behavior of mouse mast cells during anaphylaxis in vitro. Prog Allergy 1969; 13: 111–173
- Barnett J B, Justus D E. Differential effects of hemocytotropic antibodies on the mast cell and anaphylactic responses in actively and passively sensitized mice. Infect Immun 1975; 11: 1342–1351
- Foreman J, Jordan C. Hisinmine release and vascular changes induced by neuropeptides. Agents Actions 1983; 13: 105–116
- Foreman J C. Substance P and calcitonin gene-related peptide: Effects on mast cells and in human skin. Int Archs Allergy Appl Immunol 1987; 82: 366–371
- Bellinger D L, Lorton D, Romano T D, Olschowka J A, Felten S Y, Felten D L. Neulopeptide innervation of lymphoid organs. Ann NY Acad Sci USA 1990; 594: 17–33
- Holgate S T, Hardy C, Robinson C, Agius R M, Howarth P H. The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol 1986; 77: 274–282
- Busse W W. Histamine: mediator and modulator in inflammation. Chemical messengers of the inflammatory process, J C Houck. Elsevier, Amsterdam 1979; 1–45
- Kotani M, Manabe A, Seiki K, Yamashita A, Horii I. Experimental formation of lymphatic nodules in the thymus of guinea-pigs after injection of histamine. J Anat 1966; 100: 585–591
- Kotani M, Manabe A, Yamashita A, Seiki K, Horii I. Experimental formarion of lymphatic nodules in the thymus of guinea-pigs after injection of serotonin. J Anat 1967; 101: 805–812
- Enerback L. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand 1966; 66: 289–302
- Enerb Pck L. Berberine sulphate binding to mast cell polyanions: A cytofluorometric method for the quantitation of heparin. Histochemistry 1974; 42: 301–313
- Shore P A, Burkhalter A, Cohn V H. A method for the fluorometric assay of histamine in tissues. J Pharmacol exp Ther 1959; 127: 182–186
- Shirai T, Mellors R C. Natural thymocytotoxic autoantibody and reactive antigen in New Zealand Black and other mice. Proc Natl Acad Sci USA 1971; 68: 1412–1415
- Takagi M, Nakahata T, Koike K, Kobayashi T, Tsuji K, Kojima S, Hirano T, Miyajima A, Arai K, Akabane T. Stimulation of connective tissue-type mast cell proliferation by crosslinking of cell-bound IgE. J Exp Med 1989; 170: 233–244
- Plaut M, Pierce J H, Watson C J, Hanley-Hyde J, Nordan R P, Paul W E. Mast cell lines produce lymphokines in response to cross-linkage of Fc RI or to calcium ionophores. Nature (Lond) 1989; 339: 64–67
- Wodnar-Filipowicz A, Hausser C H, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature (Lond) 1989; 339: 159–162
- Smith C A, Rennick D M. Characterization of a murine lympho-kine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell grwoth factor activity that synergizes with IL-3. Proc Nail Acad Sci USA 1986; 83: 1857–1861
- Palacios R. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/WP-lpd/pr mice. Eur J Immunol 1984; 14: 599–605
- Ihle J N, Keller J, Oroszlan S, Henderson L E, Copeland T D, Fitch F, Prystowsky M B, Goldwasser E, Schrader J W. Par-aszynski E, Dy M, Lebel B. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth-factor activity, P cell-stimulating factor activity, colony-stimulating factor activity and histamine-producing cell-stimulating factor activity. J Immunol 1983; 131: 282–287